Meridiem Capital Partners LP Purchases New Position in UnitedHealth Group Incorporated (NYSE:UNH)

Meridiem Capital Partners LP bought a new stake in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 45,030 shares of the healthcare conglomerate's stock, valued at approximately $22,779,000. UnitedHealth Group comprises approximately 2.0% of Meridiem Capital Partners LP's portfolio, making the stock its 22nd biggest holding.

Other hedge funds and other institutional investors have also modified their holdings of the company. Signal Advisors Wealth LLC lifted its stake in shares of UnitedHealth Group by 13.0% in the fourth quarter. Signal Advisors Wealth LLC now owns 9,115 shares of the healthcare conglomerate's stock valued at $4,611,000 after buying an additional 1,051 shares during the period. Waycross Partners LLC lifted its position in UnitedHealth Group by 2.4% in the fourth quarter. Waycross Partners LLC now owns 27,794 shares of the healthcare conglomerate's stock worth $14,060,000 after purchasing an additional 658 shares during the period. Full Sail Capital LLC raised its stake in shares of UnitedHealth Group by 2.1% in the 4th quarter. Full Sail Capital LLC now owns 1,612 shares of the healthcare conglomerate's stock valued at $815,000 after buying an additional 33 shares in the last quarter. Czech National Bank lifted its stake in UnitedHealth Group by 6.1% during the fourth quarter. Czech National Bank now owns 199,536 shares of the healthcare conglomerate's stock worth $100,937,000 after purchasing an additional 11,426 shares during the period. Finally, Lmcg Investments LLC raised its stake in UnitedHealth Group by 11.8% during the fourth quarter. Lmcg Investments LLC now owns 37,974 shares of the healthcare conglomerate's stock worth $19,210,000 after acquiring an additional 4,022 shares in the last quarter. Institutional investors own 87.86% of the company's stock.

Wall Street Analysts Forecast Growth

UNH has been the subject of a number of research analyst reports. Erste Group Bank downgraded shares of UnitedHealth Group from a "strong-buy" rating to a "hold" rating in a research note on Wednesday, April 30th. Truist Financial lowered their price objective on UnitedHealth Group from $660.00 to $580.00 and set a "buy" rating for the company in a research report on Monday, April 21st. Barclays lowered their price target on shares of UnitedHealth Group from $513.00 to $362.00 and set an "overweight" rating for the company in a research report on Thursday. Hsbc Global Res cut shares of UnitedHealth Group from a "strong-buy" rating to a "hold" rating in a research note on Tuesday, April 22nd. Finally, Bank of America lowered UnitedHealth Group from a "buy" rating to a "neutral" rating and reduced their price target for the stock from $560.00 to $350.00 in a research report on Wednesday. Six investment analysts have rated the stock with a hold rating, eighteen have issued a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat, the company currently has a consensus rating of "Moderate Buy" and an average target price of $508.38.

UnitedHealth Group Stock Down 11.1%

Shares of UNH traded down $34.05 during midday trading on Thursday, hitting $273.96. The stock had a trading volume of 121,312,755 shares, compared to its average volume of 5,593,150. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91. The firm has a market cap of $248.52 billion, a price-to-earnings ratio of 17.67, a price-to-earnings-growth ratio of 1.37 and a beta of 0.56. The company has a 50 day simple moving average of $478.83 and a two-hundred day simple moving average of $517.83. UnitedHealth Group Incorporated has a twelve month low of $249.12 and a twelve month high of $630.73.

UnitedHealth Group (NYSE:UNH - Get Free Report) last issued its quarterly earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share for the quarter, missing the consensus estimate of $7.29 by ($0.09). The business had revenue of $109.58 billion for the quarter, compared to the consensus estimate of $111.56 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. During the same period in the prior year, the business earned $6.91 earnings per share. On average, analysts anticipate that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Tuesday, March 18th. Shareholders of record on Monday, March 10th were paid a $2.10 dividend. The ex-dividend date of this dividend was Monday, March 10th. This represents a $8.40 dividend on an annualized basis and a yield of 3.07%. UnitedHealth Group's dividend payout ratio is 35.18%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.